Steven Dabbs

990 total citations
20 papers, 664 citations indexed

About

Steven Dabbs is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Steven Dabbs has authored 20 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Organic Chemistry and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Steven Dabbs's work include Receptor Mechanisms and Signaling (6 papers), Phenothiazines and Benzothiazines Synthesis and Activities (4 papers) and Synthesis and Biological Evaluation (4 papers). Steven Dabbs is often cited by papers focused on Receptor Mechanisms and Signaling (6 papers), Phenothiazines and Benzothiazines Synthesis and Activities (4 papers) and Synthesis and Biological Evaluation (4 papers). Steven Dabbs collaborates with scholars based in United States, United Kingdom and Spain. Steven Dabbs's co-authors include Frank D. King, Graham J. Riley, D. Malcolm Duckworth, Ian T. Forbes, Steven M. Bromidge, Derek N. Middlemiss, A.J. Jennings, David R. Thomas, Jim J. Hagan and Peter J. Lovell and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron and Tetrahedron Letters.

In The Last Decade

Steven Dabbs

20 papers receiving 629 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steven Dabbs United States	13	401	269	244	57	42	20	664
Henri Stalder Switzerland	14	306 0.8×	243 0.9×	115 0.5×	110 1.9×	25 0.6×	23	570
Mark P. Wentland United States	22	640 1.6×	346 1.3×	486 2.0×	165 2.9×	97 2.3×	68	1.2k
Vivian W. Y. Liao Australia	11	233 0.6×	114 0.4×	202 0.8×	52 0.9×	13 0.3×	23	536
Marco Turconi Italy	13	212 0.5×	165 0.6×	151 0.6×	44 0.8×	40 1.0×	22	404
Minoru Moriya Japan	18	281 0.7×	88 0.3×	564 2.3×	105 1.8×	115 2.7×	40	1.1k
Fabrizio Micheli Italy	21	645 1.6×	423 1.6×	582 2.4×	71 1.2×	26 0.6×	68	1.2k
Serena Pasquini Italy	17	368 0.9×	286 1.1×	412 1.7×	288 5.1×	28 0.7×	26	918
Austin J. Reeve United States	13	253 0.6×	274 1.0×	210 0.9×	36 0.6×	34 0.8×	14	561
Clive L. Branch United States	10	251 0.6×	182 0.7×	141 0.6×	41 0.7×	8 0.2×	30	401
Ling‐Wei Hsin Taiwan	16	409 1.0×	143 0.5×	255 1.0×	78 1.4×	64 1.5×	47	827

Countries citing papers authored by Steven Dabbs

Since Specialization

Citations

This map shows the geographic impact of Steven Dabbs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Dabbs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Dabbs more than expected).

Fields of papers citing papers by Steven Dabbs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Dabbs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Dabbs. The network helps show where Steven Dabbs may publish in the future.

Co-authorship network of co-authors of Steven Dabbs

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Dabbs. A scholar is included among the top collaborators of Steven Dabbs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Dabbs. Steven Dabbs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Miles, Timothy J., Alan J. Hennessy, B.D. Bax, et al.. (2016). Novel tricyclics (e.g., GSK945237) as potent inhibitors of bacterial type IIA topoisomerases. Bioorganic & Medicinal Chemistry Letters. 26(10). 2464–2469. 33 indexed citations

Miles, Timothy J., Gerald Brooks, Pamela Brown, et al.. (2011). Novel cyclohexyl-amides as potent antibacterials targeting bacterial type IIA topoisomerases. Bioorganic & Medicinal Chemistry Letters. 21(24). 7483–7488. 33 indexed citations

Brown, Pamela, Steven Dabbs, David T. Davies, et al.. (2010). The design of efficient and selective routes to pyridyl analogues of 2,3-dihydro-1,4-benzodioxin-6-carbaldehyde. Tetrahedron Letters. 51(38). 5038–5040. 8 indexed citations

Brooks, Gerald, Pamela Brown, Steven Dabbs, et al.. (2010). Flexible palladium-catalysed amidation reactions for the synthesis of complex aryl amides. Tetrahedron Letters. 51(20). 2685–2689. 20 indexed citations

Brooks, Gerald, Steven Dabbs, David T. Davies, et al.. (2010). The design of efficient and selective routes to pyridyl analogues of 3-oxo-3,4-dihydro-2H-1,4-(benzothiazine or benzoxazine)-6-carbaldehydes. Tetrahedron Letters. 51(38). 5035–5037. 10 indexed citations

Bromidge, Steven M., Steven Dabbs, Susannah Davies, et al.. (2000). 1-[2-[(Heteroaryloxy)heteroaryl]carbamoyl]indolines: novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/Anxiolytic agents. Bioorganic & Medicinal Chemistry Letters. 10(16). 1863–1866. 16 indexed citations

Lovell, Peter J., Steven M. Bromidge, Steven Dabbs, et al.. (2000). A Novel, Potent, and Selective 5-HT₇Antagonist: (R)-3-(2-(2-(4-Methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970). Journal of Medicinal Chemistry. 43(3). 342–345. 227 indexed citations

Bromidge, Steven M., Steven Dabbs, David T. Davies, et al.. (1999). Model studies on a synthetically facile series of N-substituted phenyl-N′-pyridin-3-yl ureas leading to 1-(3-pyridylcarbamoyl) indolines that are potent and selective 5-HT2C/2B receptor antagonists. Bioorganic & Medicinal Chemistry. 7(12). 2767–2773. 5 indexed citations

Bromidge, Steven M., Steven Dabbs, David T. Davies, et al.. (1998). Novel and Selective 5-HT_2C/2B Receptor Antagonists as Potential Anxiolytic Agents: Synthesis, Quantitative Structure−Activity Relationships, and Molecular Modeling of Substituted 1-(3-Pyridylcarbamoyl)indolines. Journal of Medicinal Chemistry. 41(10). 1598–1612. 53 indexed citations

10.

Forbes, Ian T., Steven Dabbs, D. Malcolm Duckworth, et al.. (1998). (R)-3,N-Dimethyl-N-[1-methyl-3-(4-methylpiperidin-1-yl)propyl]benzenesulfonamide: The First Selective 5-HT₇Receptor Antagonist. Journal of Medicinal Chemistry. 41(5). 655–657. 86 indexed citations

11.

Forbes, Ian T., Steven Dabbs, D. Malcolm Duckworth, et al.. (1997). ChemInform Abstract: Synthesis, Biological Activity, and Molecular Modeling Studies of Selective 5‐HT2C/2B Receptor Antagonists.. ChemInform. 28(14). 1 indexed citations

12.

Bromidge, Steven M., Frank Brown, Frederick Cassidy, et al.. (1997). Design of [R-(Z)]-(+)-α-(Methoxyimino)-1-azabicyclo[2.2.2]octane-3-acetonitrile (SB 202026), a Functionally Selective Azabicyclic Muscarinic M1 Agonist Incorporating the N-Methoxy Imidoyl Nitrile Group as a Novel Ester Bioisostere. Journal of Medicinal Chemistry. 40(26). 4265–4280. 22 indexed citations

13.

Forbes, Ian T., Steven Dabbs, D. Malcolm Duckworth, et al.. (1996). Synthesis, Biological Activity, and Molecular Modeling Studies of Selective 5-HT_2C/2B Receptor Antagonists. Journal of Medicinal Chemistry. 39(25). 4966–4977. 23 indexed citations

14.

Bromidge, Steven M., Frank Brown, Frederick Cassidy, et al.. (1994). 1,2,5,6-tetrahydropyridine oxime ethers incorporating electron withdrawing groups are potent and selective muscarinic agonists. Bioorganic & Medicinal Chemistry Letters. 4(4). 557–562. 3 indexed citations

15.

Dabbs, Steven, et al.. (1994). Pseudohalogen chemistry. XI. Some aspects of the chemistry of α-thiocyanato-β-dicarbonyl compounds. Tetrahedron. 50(24). 7253–7264. 9 indexed citations

16.

Bromidge, Steven M., Frank Brown, Frederick Cassidy, et al.. (1992). A novel and selective class of azabicyclic muscarinic agonists incorporating an N-methoxy imidoyl halide or nitrile functionality. Bioorganic & Medicinal Chemistry Letters. 2(8). 791–796. 16 indexed citations

17.

Bromidge, Steven M., Frank Brown, Frederick Cassidy, et al.. (1992). Design and synthesis of azabicyclic muscarinic agonists incorporating an oxime ether functionality. Bioorganic & Medicinal Chemistry Letters. 2(8). 787–790. 8 indexed citations

18.

Dabbs, Steven, et al.. (1990). Benzotriazinones as virtual-ring mimics of o-methoxybenzamides: novel and potent 5-HT3 receptor antagonists. Journal of Medicinal Chemistry. 33(11). 2942–2944. 22 indexed citations

19.

Dabbs, Steven, et al.. (1990). 5-Hydroxytryptamine (5-HT3) receptor antagonists. 2. 1-Indolinecarboxamides. Journal of Medicinal Chemistry. 33(7). 1929–1932. 54 indexed citations

20.

Dabbs, Steven, et al.. (1990). 5-Hydroxytryptamine (5-HT3) receptor antagonists. 3. Ortho-substituted phenylureas. Journal of Medicinal Chemistry. 33(7). 1932–1935. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact